Lupin gets European Commission nod for myotonia treatment drug

Lupin said it is preparing for the launch of NaMuscla, which will occur in the initial markets of Germany and the UK in the first quarter of 2019.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news